News Release

Chinese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients in China

• New Year Greeting
• Notice of land acquisition by Beijing Continent Pharmaceutical Co., Ltd.